Heritage Wealth Management (Arizona)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2	Buy	2 +1	+100%	+$1	﹤0.01%	1077
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1121
2022 Q2	$2	Hold	1	–	–	﹤0.01%	987
2022 Q1	$0	Buy	+1	New	+$3	﹤0.01%	1004
2021 Q3	$1.15M	Hold	150,000	–	–	0.41%	48
2021 Q2	$1.45M	Hold	150,000	–	–	0.55%	35
2021 Q1	$1.24M	Buy	+150,000	New	+$1.58M	0.7%	34

Other funds holding SRNE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Heritage Wealth Management (Arizona)'s SRNE Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Sorrento Therapeutics, Inc. (SRNE) stake by 100% in Q4 2022, buying an estimated $1 and bringing the position to 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Heritage Wealth Management (Arizona) first reported a position in SRNE in Q1 2021 and has held it in 7 quarters since. The position peaked at $1.45M in Q2 2021. 223 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Heritage Wealth Management (Arizona) held 2 shares of Sorrento Therapeutics, Inc. worth $2 as of Q4 2022.
Heritage Wealth Management (Arizona) bought 1 Sorrento Therapeutics, Inc. share in Q4 2022, an estimated $1.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #1077 holding.
Heritage Wealth Management (Arizona) first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and has held it in 7 quarters since.
Heritage Wealth Management (Arizona)'s Sorrento Therapeutics, Inc. position peaked at $1.45M in Q2 2021.
223 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.